Date published: 2026-7-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

GRSF-1 Double Nickase Plasmid (h): sc-405858-NIC

0.0(0)
Write a reviewAsk a question

Datasheets
  • Target species: human
  • 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
  • GRSF-1 Double Nickase Plasmid (h) consists of a pair of plasmids each encoding a D10A mutated Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed to knockout gene expression with greater specificity than its CRISPR/Cas9 KO counterpart
  • Paired gRNA sequences are offset by approximately 20 bp to allow for specific Cas9-mediated double nicking of the genomic DNA, which mimics a DSB
  • One plasmid in the pair contains a puromycin-resistance gene for selection; the other plasmid in the pair contains a GFP marker to visually confirm transfection
  • GRSF-1 Double Nickase Plasmid (h) and GRSF-1 Double Nickase Plasmid (h2) encode distinct paired gRNA designs targeting GRSF1. One or both designs may be available
    Gene Editing Promo Banner

    Ordering Information

    Product NameCatalog #UNITPriceQtyFAVORITES

    GRSF-1 Double Nickase Plasmid (h)

    sc-405858-NIC
    20 µg
    $410.00

    GRSF-1 Double Nickase Plasmid (h2)

    sc-405858-NIC-2
    20 µg
    $410.00

    Human GRSF1 encodes GRSF-1, an RNA-binding protein enriched in mitochondria that recognizes G-rich RNA elements and modulates post-transcriptional gene regulation. GRSF-1 participates in mitochondrial RNA processing, stability, and translation, helping coordinate oxidative phosphorylation and broader mitochondrial gene expression programs. Through these functions, it contributes to cellular energy homeostasis and stress-responsive adaptation, including crosstalk between mitochondrial and nuclear pathways. Altered GRSF1 activity and mitochondrial RNA metabolism are studied in the context of disorders involving mitochondrial dysfunction, metabolic imbalance, and neurodegeneration-associated phenotypes.

    GRSF-1 Double Nickase Plasmid (h) consists of a matched pair of plasmids engineered for high-specificity editing of the GRSF1 locus in human cell lines. Each plasmid expresses a Cas9 D10A nickase and a distinct sgRNA targeting opposite DNA strands within GRSF1. When directed to adjacent sites on opposite DNA strands, the two nickases generate offset single-strand nicks that together produce a staggered double-strand break, requiring coordinated on-target activity from both guides. The resulting DNA break is resolved by endogenous cellular repair pathways, most commonly through non-homologous end joining (NHEJ), leading to insertions or deletions that disrupt GRSF1 function. By requiring dual sgRNA engagement at the target locus, the double nicking approach enhances editing specificity and provides a complementary CRISPR strategy for applications where additional control over targeting precision is desired.

    To support efficient identification of edited cells, one plasmid encodes GFP for fluorescent visualization of transfected populations, while the companion plasmid carries a puromycin resistance gene for antibiotic selection. Together, these features support efficient enrichment of co-transfected populations and simplify the validation of GRSF1-disrupted clones.

    For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.